Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis (Q38246442)

1 September 2017

0 references

Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis (English)

1 reference

Fluorodeoxyglucose Positron Emission Tomography

1 September 2017

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

Gi Jeong Cheon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

7

June-Key Chung

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Hyung-Jun Im

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kyoungjune Pak

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Seong-Jang Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

In-Joo Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

E Edmund Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Dong Soo Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

6 September 2014

1 reference

1 September 2017

number of pages

11

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

241-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25193652%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Heterogeneity Analysis of (18)F-FDG Uptake in Differentiating Between Metastatic and Inflammatory Lymph Nodes in Adenocarcinoma of the Lung: Comparison with Other Parameters and its Application in a Clinical Setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Metabolic tumor burden predicts for disease progression and death in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Additional Value of Whole-Body Fluorodeoxyglucose Positron Emission Tomography in the Detection of Distant Metastases of Non–Small-Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the Europ

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Workin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Evaluation of PET volume segmentation methods: comparisons with expert manual delineations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic significance of volume-based PET parameters in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Recent Trends in PET Image Interpretations Using Volumetric and Texture-based Quantification Methods in Nuclear Oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic significance of SUV on PET/CT in patients with esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic value of fluorine-18-fluorodeoxyglucose positron emission tomography or PET-computed tomography in cervical cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Metabolic imaging metrics correlate with survival in early stage lung cancer treated with stereotactic ablative radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Measurement of tumor volume by PET to evaluate prognosis in patients with advanced non-small cell lung cancer treated by non-surgical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Metabolic Tumor Volume Measured by F-18 FDG PET/CT can Further Stratify the Prognosis of Patients with Stage IV Non-Small Cell Lung Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Prediction for recurrence using F-18 FDG PET/CT in pathologic N0 lung adenocarcinoma after curative surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in non-small cell lung cancer: comparison of TB and non-TB endemic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Negative predictive value of positron emission tomography and computed tomography for stage T1-2N0 non-small-cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

(18)FDG-PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

A meta-analysis of ¹⁸FDG-PET-CT, ¹⁸FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Performance of whole-body PET/CT for the detection of distant malignancies in various cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Meta-analysis: accuracy of 18FDG PET-CT for distant metastasis staging in lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

Dual time point 18FDG-PET/CT versus single time point 18FDG-PET/CT for the differential diagnosis of pulmonary nodules: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

18F-FDG-PET evaluation of pathological tumour response to neoadjuvant therapy in patients with NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2903-7

18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma

21 January 2018

1 reference

12 December 2020

Evaluation of Response to Neoadjuvant Therapy by Quantitative 2-Deoxy-2-[F]Fluoro-D-Glucose with Positron Emission Tomography in Patients with Esophageal Cancer

1 reference

12 December 2020

Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.

1 reference

12 December 2020

Combining independent studies of diagnostic fluorodeoxyglucose positron-emission tomography and computed tomography in mediastinal lymph node staging for non-small cell lung cancer.

1 reference

12 December 2020

Fluorine-18 deoxyglucose Positron Emission Tomography, Magnetic Resonance Imaging and Bone Scintigraphy for the Diagnosis of Bone Metastases in Patients with Lung Cancer: Which One is the Best? – a Meta-analysis

1 reference

12 December 2020

Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer

1 reference

12 December 2020

Treatment of non-small cell lung cancer (NSCLC).

1 reference

12 December 2020